Skip to main content
Equibles

FRX · Fennec Pharmaceuticals Inc. · Investor Relations

Use FRX with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research FRX.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
13.2900 CAD -1.1700 (-8.09%) At close · Nov 5 Intraday price with Plus
Rebalance outlook locked

Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Recent news

Date Headline
2026-09-17 Fennec Pharmaceuticals Announces ORAL PRESENTATION OF DETAILED Results From Investigator-Initiated Phase 2 STS-J01 Clinical Study of PEDMARK ® in Japan AT SIOP 2026
2026-05-22 FENNEC PHARMACEUTICALS ANNOUNCES NEW RESEARCH supporting INTEGRATION AND use of pedmark ® at the 2026 ASCO Annual Meeting
2026-04-22 FENNEC PHARMACEUTICALS ANNOUNCES ACCEPTANCE of ABSTRACTS at the 2026 ASCO Annual Meeting
2026-04-07 FENNEC PHARMACEUTICALS ANNOUNCES Investigator-SPONSORED STUDY to be Conducted by University of Arizona Cancer Center
2026-03-24 FENNEC PHARMACEUTICALS REPORTS FOURTH Quarter AND FULL YEAR 2025 FINANCIAL RESULTS and provides business update
2026-03-16 FENNEC PHARMACEUTICALS ANNOUNCES SETTLEMENT AGREEMENT RESOLVING PEDMARK PATENT LITIGATION
2026-03-04 FENNEC PHARMACEUTICALS ANNOUNCES CLINICAL RESEARCH COLLABORATION WITH TAMPA GENERAL HOSPITAL CANCER INSTITUTE
2026-02-20 FENNEC PHARMACEUTICALS PRESENTS REAL WORLD DATA SUPPORTING THE integration AND CLINICAL USE OF Pedmark ® IN TREATING ADULTS WITH HEAD & nECK CANCERS
2025-12-09 FENNEC PHARMACEUTICALS ANNOUNCES Investigator-SPONSORED TRIAL to be Conducted by CITY OF HOPE IN Metastatic Testicular Germ Cell Tumors
2025-12-02 FENNEC PHARMACEUTICALS ANNOUNCES POSITIVE TOPLINE RESULTS FROM INVESTIGATOR-INITIATED CLINICAL STUDY OF PEDMARK ® IN JAPAN TO REDUCE CISPLATIN-INDUCED HEARING LOSS
2025-11-19 FENNEC PHARMACEUTICALS ANNOUNCES FULL DEBT REDEMPTION
2025-11-18 FENNEC PHARMACEUTICALS ANNOUNCES CLOSING OF PRIVATE OFFERING OF COMMON SHARES IN CANADA
2025-11-18 FENNEC PHARMACEUTICALS ANNOUNCES PRIVATE OFFERING OF COMMON SHARES IN CANADA
2025-11-17 FENNEC PHARMACEUTICALS ANNOUNCES PRICING OF OFFERING OF COMMON SHARES
2025-11-17 FENNEC PHARMACEUTICALS ANNOUNCES PROPOSED OFFERING OF COMMON SHARES

Past events

Date Event Type
2026-09-15 H.C. Wainwright 28th Annual Global Investment Conference Conference
2026-08-11 FENNEC PHARMACEUTICALS Q2 2026 CONFERENCE CALL Earnings call
2026-08-11 Fennec Pharmaceuticals Q2 2026 Conference Call Earnings call
2026-05-19 H.C. WAINWRIGHT 4TH ANNUAL BIOCONNECT INVESTOR CONFERENCE AT NASDAQ Conference
2026-05-14 FENNEC PHARMACEUTICALS Q1 2026 CONFERENCE CALL Earnings call
2026-03-24 FENNEC PHARMACEUTICALS Q4 2025 CONFERENCE CALL Earnings call
2026-03-24 Fennec Pharmaceuticals Q4 2025 Conference Call Earnings call
2025-12-03 PIPER SANDLER 37TH ANNUAL HEALTHCARE CONFERENCE Conference
2025-09-09 H.C. WAINWRIGHT 27TH ANNUAL GLOBAL INVESTMENT CONFERENCE Conference
2025-08-14 FENNEC PHARMACEUTICALS Q2 2025 CONFERENCE CALL Earnings call
2025-08-14 Fennec Pharmaceuticals Q2 2025 Conference Call Earnings call
2025-05-20 H.C. WAINWRIGHT 3RD ANNUAL BIOCONNECT INVESTOR CONFERENCE AT NASDAQ Conference
2025-05-13 FENNEC PHARMACEUTICALS Q1 2025 CONFERENCE CALL Earnings call
2025-05-13 Fennec Pharmaceuticals Q1 2025 Conference Call Earnings call
2025-03-10 FENNEC PHARMACEUTICALS Q4 2024 CONFERENCE CALL Earnings call
2025-03-10 Fennec Pharmaceuticals Q4 2024 Conference Call Earnings call
2024-12-16 HCW @ HOME WITH FENNEC PHARMACEUTICALS INC. Webcast
2024-11-07 FENNEC PHARMACEUTICALS Q3 2024 CONFERENCE CALL Earnings call
2024-11-07 Fennec Pharmaceuticals Q3 2024 Conference Call Earnings call
2024-09-19 CANTOR GLOBAL HEALTHCARE CONFERENCE Conference
2024-09-11 H.C. WAINWRIGHT 26TH ANNUAL GLOBAL INVESTMENT CONFERENCE Conference
2024-08-13 FENNEC PHARMACEUTICALS Q2 2024 CONFERENCE CALL Earnings call
2024-08-13 Fennec Pharmaceuticals Q2 2024 Conference Call Earnings call
2024-05-14 FENNEC PHARMACEUTICALS Q1 2024 CONFERENCE CALL Earnings call
2024-05-14 Fennec Pharmaceuticals Q1 2024 Conference Call Earnings call

Source: https://investors.fennecpharma.com/